| 1 |
Wang Z, Xu F, Zhao X, Zhang Y, Wang X, Zhang Z, Yang LZ, Badshah JS, Xu B, Xie R, Fang W. Expression analysis and targets prediction of microRNAs in OGD/R treated astrocyte-derived exosomes by smallRNA sequencing. Genomics 2023;115:110594. [PMID: 36863417 DOI: 10.1016/j.ygeno.2023.110594] [Reference Citation Analysis]
|
| 2 |
Morciano G, Boncompagni C, Ramaccini D, Pedriali G, Bouhamida E, Tremoli E, Giorgi C, Pinton P. Comprehensive Analysis of Mitochondrial Dynamics Alterations in Heart Diseases. Int J Mol Sci 2023;24. [PMID: 36834825 DOI: 10.3390/ijms24043414] [Reference Citation Analysis]
|
| 3 |
Alieva AM, Teplova NV, Reznik EV, Baykova IE, Shnakhova LM, Totolyan GG, Valiev RK, Skripnichenko EA, Kotikova IA, Nikitin IG. miRNA-122 as a new player in cardiovascular disease. Medical Journal of the Russian Federation 2023;28:451-463. [DOI: 10.17816/medjrf111180] [Reference Citation Analysis]
|
| 4 |
Klimczak-Tomaniak D, Haponiuk-Skwarlińska J, Kuch M, Pączek L. Crosstalk between microRNA and Oxidative Stress in Heart Failure: A Systematic Review. Int J Mol Sci 2022;23. [PMID: 36499336 DOI: 10.3390/ijms232315013] [Reference Citation Analysis]
|
| 5 |
Cong L, Bai Y, Guo Z. The crosstalk among autophagy, apoptosis, and pyroptosis in cardiovascular disease. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.997469] [Reference Citation Analysis]
|
| 6 |
Wu Y, Lan H, Zhang D, Hu Z, Zhang J, Li Z, Xia P, Tang X, Cai X, Yu P. Research progress on ncRNAs regulation of mitochondrial dynamics in diabetes. J Cell Physiol 2022. [PMID: 36125936 DOI: 10.1002/jcp.30878] [Reference Citation Analysis]
|
| 7 |
Uchikado Y, Ikeda Y, Ohishi M. Current Understanding of the Pivotal Role of Mitochondrial Dynamics in Cardiovascular Diseases and Senescence. Front Cardiovasc Med 2022;9:905072. [DOI: 10.3389/fcvm.2022.905072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Luo F, Liu W, Bu H. MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers. Heart Fail Rev 2022. [PMID: 35332416 DOI: 10.1007/s10741-022-10231-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Zhou H, Tang W, Yang J, Peng J, Guo J, Fan C. MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure. Front Cardiovasc Med 2021;8:773083. [PMID: 34869689 DOI: 10.3389/fcvm.2021.773083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Shi Y, Zhang Z, Yin Q, Fu C, Barszczyk A, Zhang X, Wang J, Yang D. Cardiac-specific overexpression of miR-122 induces mitochondria-dependent cardiomyocyte apoptosis and promotes heart failure by inhibiting Hand2. J Cell Mol Med 2021;25:5326-34. [PMID: 33942477 DOI: 10.1111/jcmm.16544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
